Ad
Monday, 17 April 2017
Roche's emicizumab hemophilia drug shows positive results with children
ZURICH (Reuters) - Roche Holding AG's emicizumab drug for treating hemophilia A showed positive interim results in a phase III study with children with inhibitors to clotting protein factor VIII, the Swiss drugmaker said on Monday.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment